American International Group, Inc. Cardiff Oncology, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.17 - $2.61 $22,121 - $49,347	-18,907 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.11 - $7.25 $2,810 - $9,657	-1,332 Reduced 6.58%	18,907 $47,000
Q4 2021 Feb 11, 2022	SELL	$5.18 - $7.24 $3,133 - $4,380	-605 Reduced 2.9%	20,239 $122,000
Q3 2021 Nov 12, 2021	BUY	$5.01 - $7.58 $2,920 - $4,419	583 Added 2.88%	20,844 $139,000
Q2 2021 Aug 13, 2021	BUY	$6.65 - $10.04 $134,735 - $203,420	20,261 New	20,261 $135,000

12.3M

813K

91.1K

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $120M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.